AI assistant
Sending…
Whitehawk Therapeutics, Inc. — Director's Dealing 2017
Nov 16, 2017
34276_dirs_2017-11-16_1405720a-312a-435a-8559-2f528947683b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Aerpio Pharmaceuticals, Inc. (ARPO)
CIK: 0001422142
Period of Report: 2017-11-15
Reporting Person: ROGERS MICHAEL W (Chief Financial Officer)
More from Whitehawk Therapeutics, Inc.
Regulatory Filings
2026
May 29
Regulatory Filings
2026
May 21
Capital/Financing Update
2026
May 13
Report Publication Announcement
2026
May 7
Director's Dealing
2025
Dec 2
Director's Dealing
2025
Dec 2
Regulatory Filings
2025
Nov 6
Interim / Quarterly Report
2025
Nov 6
Major Shareholding Notification
2025
Aug 25
Earnings Release
2025
Aug 7